共 34 条
[1]
Akiyoshi T(2012)Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255 1129-1134
[2]
Brown G(2003)Morphologic predictors of lymph node status in rectal cancer with use of high spatial resolution MR imaging with histopathologic comparison Radiology 227 371-377
[3]
Fujita S(2012)Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial Lancet Oncol 13 616-621
[4]
Akasu T(2017)Colorectal Cancer Study Group of Japan Clinical Oncology Group. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial Ann Surg 266 201-207
[5]
Mizusawa J(2017)Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up Ann Oncol 28 iv22-iv40
[6]
Saito N(2017)Applicability of American Joint Committee on Cancer and College of American pathologists regression grading system in rectal cancer Dis Colon Rectum 60 815-826
[7]
Kinugasa Y(2004)High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 52 78-83
[8]
Kanemitsu Y(2017)Is there any reason to still consider lateral lymph node dissection in rectal cancer? rationale and technique Clin Colon Rectal Surg 30 346-356
[9]
Ohue M(2019)Neoadjuvant (Chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer J Clin Oncol 37 33-43
[10]
Fujii S(2003)Training and quality assurance for rectal cancer: 20 years of data is enough Lancet Oncol 4 695-702